... investors, and financial analysts ... Investor Relations. A new way to treat disease is ... Stock Information. NASDAQ: RGNX. $15.43. Apr 22 ...
Mar 11, 2024. REGENXBIO to Participate in Upcoming Investor Conferences. Mar 06, 2024. REGENXBIO Announces Pricing of Upsized Public Offering of Common Stock ...
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Contact Us · Terms and ...
Missing: rgnx | Show results with:rgnx
People also ask
Where is Regenxbio located?
What is the mission statement of Regenxbio?
What is the phone number for Regenxbio?
What is RGX 314?
REGENXBIO to Host Conference Call on February 27 to Discuss Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights.
Missing: rgnx | Show results with:rgnx
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
According to Zacks Investment Research, based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is $-1.28. The reported EPS for the same ...
Find the latest REGENXBIO Inc. (RGNX) stock quote, history, news and other vital information to help you with your stock trading and investing.